Skip to main content
Caplight Logo









Akkure

Akkure

Private
DublinHealthcare & Life Scienceshttps://www.akkure.com/

Last Round

Grant

Nov 21, 2022

Est. Valuation

$6.27M

Total Funding Raised

$3.6M

Company Overview

Akkure is a health technology company that provides an AI-powered platform for clinical trial recruitment and genomic data analytics.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Precision Medicine, Medical AI, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts, Usage-Based SaaS

AI Layer

Application

Keywords

clinical trial recruitmentgenomic data analyticsprecision medicinepatient matchingmedical digital twinsdigital healthhealth techelectronic health recordsEHRblockchain healthcaredecentralized health dataAI clinical trialstele-trialspatient data ownershipclinical trial software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akkure Comparables

Compare Akkure with similar companies based on industry and business-model similarity.

Akkure comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ancora.ai
82%
Massive Bio
78%
Power
76%

Akkure Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 21, 2022
CrowdfundingNov 21, 2022
CrowdfundingFeb 11, 2021
GrantDec 1, 2019

Akkure Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 21, 2022

    $1M raised from Spark Venture Funding.

  • Nov 21, 2022

    $710K raised from Department of Enterprise, Trade and Employment.

Akkure Filings

Explore SEC and related filing metadata, where available.

Akkure filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Akkure's valuation, stock price, and market status.

Is Akkure a public or private company?

Akkure is a private company.

What is the current stock price of Akkure?

Akkure is a private company with no public stock price. Caplight tracks Akkure's secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is Akkure worth (valuation)?

Akkure's valuation is estimated at $6.3M based on funding round data.

Can I buy Akkure stock?

Akkure shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Akkure's last funding round?

Akkure's most recent funding round was Grant on February 11, 2021.

Who are the main investors in Akkure?

Key investors in Akkure include Department of Enterprise, Trade and Employment, Spark Venture Funding, Enterprise Ireland.

Will Akkure IPO soon?

No public IPO plans have been announced for Akkure.

How can I track Akkure secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Akkure's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDublin
Employee Range1
Year Founded2019
Last FundingNov 21, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?